BioCentury
ARTICLE | Clinical News

HerpV with QS-21: Completed Phase IIa enrollment

March 11, 2013 7:00 AM UTC

Agenus completed enrollment of >=75 HSV-2-positive patients with a history of frequent disease recurrence in the double-blind, placebo-controlled, U.S. Phase IIa C-400-02 trial evaluating HerpV plus A...